BrainScope raised $2.5 million, according to an SEC filing, bringing the total funds to date to at least $6.2 million. The Bethesda, Maryland-based company developed mobile, non-invasive devices that help medical professionals assess Traumatic Brain Injury (TBI) in the field, providing a middle ground between a CT scan and the questionnaire.

BrainScope currently offers two devices – Ahead 100, which was cleared in November 2014; and Ahead 200, which is smaller and more rugged than the Ahead 100. Cleared in May, the Ahead 200 consists of a headpiece with a number of EEG leads that connect to a companion app running on an Android smartphone or tablet. The device is FDA-cleared for prescription use by trained medical professionals only.

In addition, the company is also working on another assessment device with significant support from the US Department of Defense (DoD), GE, and the National Football League (NFL). As part of that co-operation, BrainScope received $500,000 from GE and the NFL, as well as more than $27 million from the DoD.

[Via: mobihealthnews]